Active ingredientBivalirudinCat. No. P-B091-001CAS 128270-60-0Family · Pharmaceutical analytical standards
Bivalirudin
An injectable anticoagulant that directly inhibits thrombin: a synthetic 20-amino-acid peptide designed in the early 1990s and approved in the United States in 2000 for coronary angioplasty procedures. This family brings together the active ingredient and other impurities.
Did you know?It mimics hirudin, the anticoagulant in the saliva of the medicinal leech Hirudo medicinalis, packing into a small peptide just the parts needed to block thrombin.
Go to the active ingredient →Active ingredientBivalirudinCat. No. P-B091-001CAS 128270-60-0
ImpurityBivalirudin Impurity 1Cat. No. P-B091-002CAS 72378-50-8
ImpurityBivalirudin Impurity 2Cat. No. P-B091-006
ImpurityBivalirudin Impurity 3Cat. No. P-B091-007CAS 1310025-28-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.